In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD

Autor: Angela Marina Montalbano, Maria Ferraro, Mirella Profita, Stefania Gerbino, Giusy Daniela Albano, Loredana Riccobono, Mark Gjomarkaj, Anna Bonanno, Paola Casarosa, Michael P. Pieper
Přispěvatelé: Profita, M, Riccobono, L, Montalbano, AM, Bonanno, A, Ferraro, M, Albano, GD, Gerbino, S, Casarosa, P, Pieper, MP, Gjomarkaj, M
Rok vydání: 2012
Předmět:
Zdroj: Immunobiology. 217:345-353
ISSN: 0171-2985
DOI: 10.1016/j.imbio.2011.07.013
Popis: Novel pharmacological strategies are aimed at the resolution of systemic inflammation in COPD potentiating peripheral blood T-cell (PBT-cell) apoptosis. Although muscarinic acetylcholine receptors (mAChRs) M(3) and choline-acetyltransferase (ChAT) participate in the airway inflammation of COPD, their role in PBT-cell apoptosis remains unexplained. We evaluated in PBT-cells from COPD patients, smoker (S) and control (C) subjects: (1) apoptosis (by annexin V binding), (2) mAChR M(3) and ChAT expression, acetylcholine (ACh)-binding; (3) choline levels in serum and PBT-cells extracts. We tested the effects of Tiotropium (Spiriva(®)) and hemicholinium-3 (HCh-3) on apoptosis, NFκB pathway, caspases 3 and 8 activity and choline levels, in PBT-cells from COPD patients. We showed that: (1) apoptosis, mAChR M(3) and ChAT expression and the CD3+ and CD8+ ACh-binding are increased in PBT-cells from COPD patients when compared to C subjects, while CD4+/CD8+ ratio of ACh-binding to PBT cells was reduced in COPD; (2) choline levels are higher in serum and PBT-cells extracts from COPD patients than in S and C; (3) Tiotropium and HCh-3 reduced CD4+ and increased CD8+ apoptosis via caspases 3 and 8 activities and via IκB mediated mechanisms in COPD patients. This study suggests the involvement of non-neuronal components of cholinergic system in the regulation of PBT-cell apoptosis in COPD and demonstrates that Tiotropium regulates CD4+ and CD8+ PBT-cell apoptosis. It provides novel putative pharmacological targets for the resolution of systemic inflammation in COPD.
Databáze: OpenAIRE